Treatment of Acanthamoeba keratitis

Cornea

Volumn 17, Issue 1, 1998, Pages 11-16

  Lindquist, Thomas D ^a  

^a VIRGINIA MASON MEDICAL CENTER   (United States)

Author keywords

Acanthamoeba keratitis; Chlorhexidine; Polyhexamethylene biguanide (PHMB); Propamidine; Treatment

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIAMEBIC AGENT; ANTIINFECTIVE AGENT; CHLORHEXIDINE; CLOTRIMAZOLE; CORTICOSTEROID; DEXAMETHASONE; DIAMIDINE DERIVATIVE; DIBROMPROPAMIDINE; DIMETHYL SULFOXIDE; DIMINAZENE ACETURATE; HEXAMIDINE ISETIONATE; HYDROXYSTILBAMIDINE ISETIONATE; IMIDAZOLE DERIVATIVE; ITRACONAZOLE; KETOCONAZOLE; MICONAZOLE; NEOMYCIN; PAROMOMYCIN; PENTAMIDINE ISETHIONATE; POLY(HEXAMETHYLENEBIGUANIDE); PROPAMIDINE ISETHIONATE;

ACANTHAMOEBA; ANTISEPSIS; CRYOTHERAPY; DEBRIDEMENT; DRUG EFFICACY; DRUG POTENTIATION; EARLY DIAGNOSIS; HUMAN; KERATITIS; NONHUMAN; PENETRATING KERATOPLASTY; PRIORITY JOURNAL; PROTOZOAL INFECTION; REVIEW; TOPICAL DRUG ADMINISTRATION; TREATMENT PLANNING;

ACANTHAMOEBA KERATITIS; ANIMALS; ANTIPROTOZOAL AGENTS; CORNEA; CRYOSURGERY; DISINFECTANTS; DRUG THERAPY, COMBINATION; HUMANS; KERATOPLASTY, PENETRATING; OPHTHALMIC SOLUTIONS;

EID: 0031985486     PISSN: 02773740     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003226-199801000-00002     Document Type: Review

References (79)

1. Auran JD, Starr MB, Jakobiec FA. Acanthamoeba keratitis: a review of the literature. Cornea 1987;6:2-26.
2. Chynn EW, Lopez MA, Pavan-Langston D, Talamo JH. Acanthamoeba keratitis: contact lens and noncontact lens characteristics. Ophthalmology 1995;102:1369-73.
3. Lindquist TD, Doughman DJ, Rubenstein JB, Moore JW, Campbell RC. Acanthamoeba-contaminated hydrogel contact lenses. Cornea 1988;7:300-3.
4. Ludwig IH, Meisler DM, Rutherford I, et al. Susceptibility of Acanthamoeba to soft contact lens disinfection systems. Invest Ophthalmol Vis Sci 1986;27:626-8.
5. Florakis FJ, Solberg R, Krachmer JG, Tse DT, Roussel TJ, Vrabec MP. Elevated corneal epithelial lines in Acanthamoeba keratitis. Arch Ophthalmol 1988;106:1202-6.
6. Lindquist TD, Sher NA, Doughman DJ. Clinical signs and medical therapy of early Acanthamoeba keratitis. Arch Ophthalmol 1988; 106:73-7.
7. Moore MB, McCulley JP, Kaufman HE, Robin JB. Radial keratoneuritis as a presenting sign of Acanthamoeba keratitis. Ophthalmology 1986;93:1310-5.
8. Holland GN, Donzis PB. Rapid resolution of early Acanthamoeba keratitis after epithelial débridement. Am J Ophthalmol 1987;104: 87-9.
9. Mortality and Morbidity Weekly Report. Acanthamoeba keratitis associated with contact lenses - United States. MMWR 1986;35: 405-9.
10. Mathers WD, Goldberg MA, Sutphin JE, Ditkoff JW, Folberg R. Coexistent Acanthamoeba keratitis and herpetic keratitis. Arch Ophthalmol 1997;115:714-8.
11. Mannis MJ, Tamaru R, Roth AM, Burns M, Thirkill C. Acanthamoeba sclerokeratitis: determining diagnostic criteria. Arch Ophthalmol 1986;104:1313-7.
12. McClellan K, Coster DJ. Acanthamoeba keratitis diagnosed by paracentesis and biopsy and treated with propamidine. Br J Ophthalmol 1987;71:734-6.
13. Moore MB, McCulley JP, Luckenbach MD, et al. Acanthamoeba keratitis associated with soft contact lenses. Am J Ophthalmol 1985;100:396-403.
14. Theodore FH, Jakobiec FA, Juechter KB, et al. The diagnostic value of a ring infiltrate in acanthamoebic keratitis. Ophthalmology 1985;92:1471-9.
15. Moore MB, McCulley JP. Acanthamoeba keratitis associated with contact lenses: six consecutive cases of successful management. Br J Ophthalmol 1989;73:271-5.
16. Scully RE, Mark ES, McNeely BU. Case records of the Massachusetts General Hospital: weekly clinicopathological exercises: case 10 - 1985. N Engl J Med 1985;312:634-41.
17. Mondino BJ, Rabin BS, Kessler E, Gallo J, Brow SI. Corneal rings with gram-negative bacteria. Arch Ophthalmol 1977;95:2222-5.
18. Wessely K. Ueber anaphylaktische Erscheinungen an der Hornhaut. Munch Med Wochenschr 1911;58:1713-4.
19. Ishibashi Y, Matsumoto Y, Kabata T, et al. Oral itraconazole and topical miconazole with débridement for Acanthamoeba keratitis. Am J Ophthalmol 1990;109:121-6.
20. Bacon AS, Dart JKG, Ficker LA, Matheson MM, Wright P. Acanthamoeba keratitis: the value of early diagnosis. Ophthalmology 1993;100:1238-43.
21. Bacon AS, Frazer DG, Dart JKG, Matheson M, Ficker LA, Wright P. A review of 72 consecutive cases of Acanthamoeba keratitis: 1984-1992. Eye 1993;7:719-25.
22. Illingworth CD, Cook SD, Karabatsas CH, Easty DL. Acanthamoeba keratitis: risk factors and outcome. Br J Ophthalmol 1995; 79:1078-82.
23. Brooks JG Jr, Coster DJ, Badenoch PR. Acanthamoeba keratitis: resolution after epithelial débridement. Cornea 1994;13:186-9.
24. Elder MJ, Kilvington S, Dart JKG. A clinicopathologic study of in vitro sensitivity testing and Acanthamoeba keratitis. Invest Ophthalmol Vis Sci 1994;35:1059-64.
25. Hay J, Kirkness CM, Seal DV, Wright P. Drug resistance and Acanthamoeba keratitis: the quest for alternative antiprotozoal chemotherapy. Eye 1994;8:555-63.
26. Kuyyakanond T, Quesnel LB. The mechanism of action of chlorhexidine. FEMS Microbiol Lett 1992;100:211-6.
27. Seal DV, Hay J, Kirkness CM. Chlorhexidine or polyhexamethylene biguanide for acanthamoeba keratitis. Lancet 1995;345:136.
28. Booth A, Morrell AJ. Letters to the editor. Eye 1994;8:719-20.
29. Kilvington S. Chemotherapy for Acanthamoeba keratitis. Lancet 1995;345:792.
30. Larkin DFP, Kilvington S, Dart JKG. Treatment of Acanthamoeba keratitis with polyhexamethylene biguanide. Ophthalmology 1992; 99:185-91.
31. Mills RA, Wilhelmus KR, Osato MS, Pyron M. Polyhexamethylene biguanide in the treatment of Acanthamoeba keratitis. Aust N Z J Ophthalmol 1993;21:277-8.
32. Varga JH, Wolf TC, Jensen HG, et al. Combined treatment of Acanthamoeba keratitis with propamidine, neomycin, and polyhexamethylene biguanide. Am J Ophthalmol 1993;115:466-70.
33. Berry M, Easty DL. Isolated human and rabbit eye: models of corneal toxicity. Toxicol In Vitro 1993;7:461-4.
34. Archer HG, Barnett S, Irving S, Middleton KR, Seal DV. A controlled model of moist wound healing: comparison between semipermeable film, antiseptics and sugar paste. J Exp Pathol 1990; 71:155-70.
35. Green K, Livingston V, Bowman K, Hull DS. Chlorhexidine effects on corneal epithelium and endothelium. Arch Ophthalmol 1980;98:1273-8.
36. Elder MJ, Dart JKG. Chemotherapy for Acanthamoeba keratitis. Lancet 1995;345:791.
37. Seal DV, Hay J, Connor R, Cairns D. Guanidines, diamidines, and biguanides: towards a rational therapy for Acanthamoeba keratitis. Ocular Microbiology and Immunology Group, 29th Annual Meeting, Atlanta, October 28, 1995:37.
38. Wright P, Warhurst D, Jones BR. Acanthamoeba keratitis successfully treated medically. Br J Ophthalmol 1985;69:778-82.
39. Berger ST, Mondino BJ, Hoft RH, et al. Successful medical management of Acanthamoeba keratitis. Am J Ophthalmol 1990;110: 395-403.
40. D'Aversa G, Stern GA, Driebe WT Jr. Diagnosis and successful medical treatment of Acanthamoeba keratitis. Arch Ophthalmol 1995;113:1120-3.
41. Kilvington S, Larkin DFP, White DG, Beeching JR. Laboratory investigation of Acanthamoeba keratitis. J Clin Microbiol 1990; 28:2722-5.
42. Wilhelmus KR, Osato MS, Font RL, Robinson NM, Jones DB. Rapid diagnosis of Acanthamoeba keratitis using calcofluor white. Arch Ophthalmol 1986;104:1309-12.
43. Brasseur G, Favennec L, Perrine D, Chenu JP, Brasseur P. Successful treatment of Acanthamoeba keratitis by hexamidine. Cornea 1994;13:459-62.
44. Casemore DP. Sensitivity of Hartmannella (Acanthamoeba) to 5-fluorocystosine, hydroxystilbamidine and other substances. J Clin Pathol 1970;23:649-52.
45. Nagington J, Richards JE. Chemotherapeutic compounds and Acanthamoeba from eye infections. J Clin Pathol 1976;29:648-51.
46. Perrine D, Barbier D, Chenu P, Georges P. Comparative study of cysticidal effects of three diamidines on Acanthamoeba strains isolated from keratitis. VIth Int'l Conference on the Biology and Pathogenicity of Free-Living Amoebae 1992: abstract 288.
47. Hugo ER, Byers TJ. S-Adenosyl-L-methionine decarboxylase of Acanthamoeba castellanii (Neff): purification and properties. Biochem J 1993;295:203-9.
48. Greenidge PA, Jenkins TC, Neidle S. DNA minor groove recognition properties of pentamidine and its analogs: a molecular modelling study. Mol Pharmacol 1993;43:982-8.
49. Jenkins TC, Lane AN, Neidle S, Brown DG. NMR and molecular modeling studies of the interaction of berenil and pentamidine with d(CGCAAATTTGCG)2. Eur J Biochem 1993;213:1175-84.
50. Arnott MA, Hay J. The effect of pentamidine salts on the NADPH-oxidase system of stimulated neutrophilic granulocytes. J Antimicrob Chemother 1990;25:247-53.
51. Arnott MA, Bennett ND, Cairns D, Hay J. Selective effects of pentamidine on cytosolic and granule-associated enzyme release from zymosan-activated human neutrophilic granulocytes. J Pharm Pharmacol 1994;46:394-6.
52. Johns KJ, Head WS, O'Day DM. Corneal toxicity of propamidine. Arch Ophthalmol 1988;106:68-9.
53. Moore MB, McCulley JP, Newton C, et al. Acanthamoeba keratitis: a growing problem in soft and hard contact lens wearers. Ophthalmology 1987;94:1654-61.
54. Osato MS, Robinson NM, Wilhelmus KR, Jones DB. In vitro evaluation of antimicrobial compounds for cysticidal activity against Acanthamoeba. Rev Infect Dis 1991;13(suppl 5):S431-4.
55. Wilson FM II. Toxic and allergic reactions to topical ophthalmic medications. In: Arffa RC, ed. Grayson's diseases of the cornea, 3rd ed. St. Louis: Mosby Year Book, 1991;632-4.
56. Cohen EJ, Parlato CJ, Arentsen JJ, et al. Medical and surgical treatment of Acanthamoeba keratitis. Am J Ophthalmol 1987;03: 615-25.
57. Hirst LW, Green WR, Merz W, et al. Management of Acanthamoeba keratitis: a case report and review of the literature. Ophthalmology 1984;1:1105-11.
58. Driebe WT, Stern GA, Epstein RJ, Visvesvara GS, Adi M, Komadina T. Acanthamoeba keratitis. Arch Ophthalmol 1988;106: 1196-201.
59. Epstein RJ, Wilson LA, Visvesvara GS, Plourde EG Jr. Rapid diagnosis of Acanthamoeba keratitis from corneal scrapings using indirect fluorescent antibody staining. Arch Ophthalmol 1986;104: 1318-21.
60. Ficker L, Seal D, Warhurst D, Wright P. Acanthamoeba keratitis: resistance to medical therapy. Eye 1990;4:835-8.
61. Schuster FL. Comparative effects of selected azole compounds on trophic and cystic stages of Acanthamoeba polyphaga. J Eukaryot Microbiol 1993;40:563-9.
62. Gilbert ML, Osato MS, Wilhelmus KR. Ocular toxicity of topical clotrimazole preparations. J Toxicol 1987;6:3-7.
63. Samples JR, Binder PS, Luibel FJ, Font RL, Visvesvara GS, Peter CR. Acanthamoeba keratitis possibly acquired from a hot tub. Arch Ophthalmol 1984;102:707-10.
64. Saunders PPR, Proctor EM, Rollins DF, Richards JSF. Enhanced killing of Acanthamoeba cysts in vitro using dimethylsulfoxide. Ophthalmology 1992;99:1197-200.
65. Osato M, Robinson N, Wilhelmus K, Jones D. Morphogenesis of Acanthamoeba castellanii: titration of the steroid effect. Invest Ophthalmol Vis Sci Suppl 1986;27:37.
66. John T, Lin J, Sahm D, Rockey JH. Effects of corticosteroids in experimental Acanthamoeba keratitis. Rev Infect Dis 1991;13S: S440-2.
67. Park DH, Palay DA, Daya SM, Stulting RD, Krachmer JH, Holland EJ. The role of topical corticosteroids in the management of Acanthamoeba keratitis. Cornea 1997;16:277-83.
68. Meisler DM, Ludwig IH, Rutherford I, Bican FE, Langston RHS, Visvesvara GS. Susceptibility of Acanthamoeba to cryotherapeutic methods. Arch Ophthalmol 1986;104:130-1.
69. Binder PS. Cryotherapy for medically unresponsive Acanthamoeba keratitis. Cornea 1989;8:106-14.
70. Byers TJ. Growth, reproduction, and differentiation in Acanthamoeba. Int Rev Cytol 1979:61:283-338.
71. Larkin DFP, Berry M, Easty DL. In vitro corneal pathogenicity of Acanthamoeba. Eye 1991;5:560-8.
72. Stopak SS, Roat MI, Nauheim RC, et al. Growth of Acanthamoeba on human corneal epithelial cells and keratocytes in vitro. Invest Ophthalmol Vis Sci 1991;32:354-9.
73. Matoba AY, Pare PD, Le TD, Osato MS. The effects of freezing and antibiotics on the viability of Acanthamoeba cysts. Arch Ophthalmol 1989;107:439-40.
74. Blackman HJ, Rao NA, Lemp MA, Visvesvara GS. Acanthamoeba keratitis successfully treated with penetrating keratoplasty: suggested immunogenic mechanism of action. Cornea 1984;3: 125-30.
75. Cohen EJ, Buchanan HW, Laughrea PA, et al. Diagnosis and management of Acanthamoeba keratitis. Am J Ophthalmol 1985;100: 389-95.
76. Hamburg A, De Jonckheere JF. Amoebic keratitis. Ophthalmologica 1980;181:74-80.
77. Lund OE, Stefani FH, Dechant W. Amoebic keratitis: a clinico-pathologic case report. Br J Ophthalmol 1978;62:373-5.
78. Margo CE, Brinser JH, Groden L. Exfoliated cytopathology of Acanthamoeba keratitis. JAMA 1986;255:2216.
79. Ficker LA, Kirkness C, Wright P. Prognosis for keratoplasty in Acanthamoeba keratitis. Ophthalmology 1992;100:105-10.